Abstract
Method: Paramedics from rural Wales were trained in the acquisition and recognition of 12 lead ECGs, and also in the modified indications for thrombolytic therapy as defined by the Joint Royal Colleges Ambulance Liaison Committee (JRCALC). Ninety six consecutive patients, with possible myocardial infarction, were included in the study. The paramedics made an independent decision regarding the eligibility of the patients for thrombolysis before hospital admission, noting the time that they could have administered the drug. These decisions were compared with the treatment subsequently received in hospital.
Results: No errors were made by the paramedics in case selection (specificity of 100% (95% CI 95.9% to 100%)). There was a potential reduction in call to needle time of 41.2 minutes (95% CI 25.7 minutes to 56.9 minutes, p=0.001).
Conclusions: It was concluded that the paramedic selection of patients for the prehospital administration of a thrombolytic is both feasible and safe.
Full Text
The Full Text of this article is available as a PDF (88.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Karnash S. L., Granger C. B., White H. D., Woodlief L. H., Topol E. J., Califf R. M. Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial. J Am Coll Cardiol. 1995 Dec;26(7):1651–1656. doi: 10.1016/0735-1097(95)00386-x. [DOI] [PubMed] [Google Scholar]
- Krucoff M. W., Croll M. A., Pope J. E., Pieper K. S., Kanani P. M., Granger C. B., Veldkamp R. F., Wagner B. L., Sawchak S. T., Califf R. M. Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol. 1993 Jan 15;71(2):145–151. doi: 10.1016/0002-9149(93)90729-v. [DOI] [PubMed] [Google Scholar]
- Maggioni A. P., Franzosi M. G., Santoro E., White H., Van de Werf F., Tognoni G. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group. N Engl J Med. 1992 Jul 2;327(1):1–6. doi: 10.1056/NEJM199207023270101. [DOI] [PubMed] [Google Scholar]
- Rawles J. M. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol. 1997 Nov 1;30(5):1181–1186. doi: 10.1016/s0735-1097(97)00299-4. [DOI] [PubMed] [Google Scholar]
- White H. D., Van de Werf F. J. Thrombolysis for acute myocardial infarction. Circulation. 1998 Apr 28;97(16):1632–1646. doi: 10.1161/01.cir.97.16.1632. [DOI] [PubMed] [Google Scholar]
- Yellon D. M., Hearse D. J., Crome R., Wyse R. K. Temporal and spatial characteristics of evolving cell injury during regional myocardial ischemia in the dog: the "border zone" controversy. J Am Coll Cardiol. 1983 Oct;2(4):661–670. doi: 10.1016/s0735-1097(83)80306-4. [DOI] [PubMed] [Google Scholar]